logo-loader
HealthCannabis
viewPharmaCielo

Full interview: PharmaCielo looking to 2020 as a transformative year for the cannabis company

PharmaCielo (CVE: PCLO) Chief Corporate Officer David Gordon joined Steve Darling from Proactive in Toronto to talk about the cannabis company whose operations are in Colombia. Gordon talked about the facilities they have and the advantages the climate in Colombia has for growing. 

Gordon also told Proactive about two key deal recently, One with Creso Pharma and General Extract.

Quick facts: PharmaCielo

Price: 3.25 CAD

TSX-V:PCLO
Market: TSX-V
Market Cap: $312.91 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

1 day, 4 hours ago

2 min read